PPA
OSIR

Parametric Portfolio Associates’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Parametric Portfolio Associates’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-12,618
Closed -$63K – 3887
2016
Q3 		$63K Buy
12,618
+417
+3% +$2.13K ﹤0.01% 3721
2016
Q2 		$62K Buy
+12,201
New +$65.7K ﹤0.01% 3769

Other funds holding OSIR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parametric Portfolio Associates's OSIR Position: Q4 2016 in Review

Parametric Portfolio Associates sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2016, closing a stake of 12,618 shares — an estimated $63K sold.

Parametric Portfolio Associates first reported a position in OSIR in Q2 2016 and held it in 2 quarters. The position peaked at $63K in Q3 2016. 64 funds tracked by Wall St. Rank hold OSIR as of Q4 2016.

  • Parametric Portfolio Associates reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Parametric Portfolio Associates sold 12,618 Osiris Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $63K.
  • Parametric Portfolio Associates first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
  • Parametric Portfolio Associates's Osiris Therapeutics, Inc. Common Stock position peaked at $63K in Q3 2016.
  • 64 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Parametric Portfolio Associates's 13F filing for Q4 2016, filed 14 Feb 2017.